Company profile for IRICoR

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IRICoR, a Centre of Excellence in Commercialization and Research specialized in drug discovery, has become a key player in the sector both nationally and internationally. IRICoR plays an increasingly pivotal role in the development of novel therapies in cancer and related areas. The mandate of this not-for-profit organization is to facilitate and accelerate the transformation of research results into innovation for the bene...
IRICoR, a Centre of Excellence in Commercialization and Research specialized in drug discovery, has become a key player in the sector both nationally and internationally. IRICoR plays an increasingly pivotal role in the development of novel therapies in cancer and related areas. The mandate of this not-for-profit organization is to facilitate and accelerate the transformation of research results into innovation for the benefit of patients. IRICoR stands out by the strategic support it provides at all stages of drug development towards commercialization of innovative therapeutic solutions.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
C.P. 6128, Downtown station Montreal (Quebec) H3C 3J7
Telephone
Telephone
+514 343‑6647
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/the-institute-for-research-in-immunology-and-cancer-iric-of-the-universite-de-montreal-and-iricor-announce-initiation-of-phase-1-trial-of-licensed-small-molecule-therapy-for-solid-tumors-302499345.html

PR NEWSWIRE
09 Jul 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty